AGP Picks
View all

Catch up with telecommunications news from the world

Provided by AGP

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on May 12, 2026

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 
[Latest] Industrial Lubricant Market Size Will Attain USD 102.90 Billion by 2034 Growing at 5.80% CAGR - Exclusive Report by Zion Market Research
21shares Launches THYP and TXXH, the First U.S. ETFs Tracking Hyperliquid
Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress
Ammonia Market worth $102.74 billion by 2031, at 3.71%, says MarketsandMarkets™
Uniti Wholesale Accelerates with FastWaves™
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
Picogrid Joins U.S. Army’s “Right to Integrate” Sprint at Fort Carson to Accelerate Vendor-Neutral Interoperability
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026
Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits
Star Bulk Announces Results of Its 2026 Annual Meeting of Shareholders

Share us

on your social networks:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.